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Abstract  Experiments were performed in bovine chromaf-
fin cells in short term primary culture. Tetrandrine is a plant
alkaloid from the chinese medical herb Stefania tetrandra.
The aim of the present study was to investigate the mecha-
nisms by which tetrandrine interacts with calcium signal-
ling and to provide a quantitative description of effects. Te-
trandrine blocked voltage-operated calcium channel cur-
rents concentration-dependently as shown in whole cell
patch-clamp recordings. The blockade of calcium channels
reduced the potassium-stimulated catecholamine release.
Besides, the drug increased the spontaneous (not stimulat-
ed) release of catecholamines in the presence of extracellu-
lar calcium. Measurements of intracellular calcium levels
[Ca]i showed a calcium release from intracellular stores by
tetrandrine. This tetrandrine-induced [Ca]i elevation was
higher in calcium containing as compared to calcium free
solution. Tetrandrine effects partially overlap with those of
thapsigargin, but tetrandrine has additional targets, since it
increased [Ca]i in cells pretreated with thapsigargin. We
conclude that tetrandrine blocks voltage-operated calcium
channels and increases [Ca]i by blocking endoplasmic and
other calcium pumps.
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Introduction
Tetrandrine is a bis-benzyl-isoquinoline alkaloid, which
can be isolated from the roots of the chinese medical herb
Stefania tetrandra. It has long been used for the treatment of
hypertension, inflammation and, more recently, silicosis
(Bingci et al. 1982). The isolated active compound tetran-
drine has biological activities in vascular and lymphatic tis-
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sue as well as in lung tissue (Miles et al. 1993), smooth
muscle (Kwan and Wang 1993) and nervous tissue from
mammals and insects (King et al. 1988; Bickmeyer et al.
1994; Wiegand et al. 1996). It has been described not only
to affect the binding properties of other compounds to cal-
cium channels (King et al. 1988), but also to block calcium
channels in different tissues: L-type channels, T-type chan-
nels, N-type channels (Felix et al. 1992; Liu et al. 1992;
Rossier et al. 1993; Bickmeyer and Wiegand 1993) and P-
type channels (Weinsberg et al. 1994; Weinsberg 1995).
Several investigations suggest, that tetrandrine additionally
interacts with the intracellular calcium homeostasis of such
different cells like lymphocytes and neuroblastoma cells
(Miles et al. 1993; Bickmeyer et al. 1996). The aim of the
present study is to investigate the mechanisms by which te-
trandrine interacts with calcium signalling in bovine chro-
maffin cells, which are well suited for investigations with
different methods like patch-clamp, determination of cate-
cholamine release and calcium fluorimetry.
Materials and methods
Culture method. Primary cultures of bovine chromaffin cells were
prepared (Marxen et al. 1989) and kept in culture medium containing:
Dulbecco’s modified eagle medium (DMEM) 10 g/l, glucose 33 mM,
NaHCO3 36 mM, glutamine 7 mM, 10% fetal calf serum, 100 U/ml
penicillin/streptomycine, fluordesoxyuridine 10 m M, uridine 10 m M
and cytosinarabinoside 10 m mM. Cells were cultured at a densitiy of
500.000/ml.
Electrophysiology. The recordings were done with the EPC-7 patch
clamp amplifier (List electronics) and analyzed with the computer
programm CED Electrophysiology package V5.5 (Cambridge Elec-
tronic Design). All recordings were carried out between Day 1 and
Day 3 of culture. The bath solution contained: tetraethylammonium-
chloride (TEA) 135 mM, N-(2hydroxyethyl)piperazine-N-2-et-
hanesulfonicacid (HEPES) 10 mM, MgCl2 1.2 mM, BaCl2 10 mM,
tetrodotoxin (TTX) 2 m M (pH was adjusted to 7.2 with TEA-OH).
Barium currents through calcium channels were recorded with fi-
repolished patch pipettes with 2–7M(resistance. Pipette solution:
CsCl 135 mM, HEPES 10 mM, ethyleneglycol-bis(2-aminoethylet-
her)-N,N,N’-tetraaceticacid (EGTA) 10 mM, MgCl2 2 mM, Na-ATP
4 mM (pH was adjusted to 7.2 with TEA-OH). Calcium channel cur-
rents were evoked from a holding potential of –70 to 0 mV for 100 ms
every 30 s. For concentration effect curves, current amplitudes were
determined before and 10 min after tetrandrine application. Current
amplitudes were measured 90 ms after the onset of stimuli lasting for
100 ms.
Analysis of catecholamine release. Cells were washed twice using as
experimental buffer HEPES buffered saline (HBS, containing in mM:
NaCl 150, KCL 5.4, CaCl2 1.8, HEPES 20, MgSO4 0.8, d-glucose
20). For chemical depolarisation of the cells, 50 mM K+ was applied
for 5 min and the catecholamine content of the buffer was determined
using high-performance-liquid-chromatography (HPLC). Effects of
tetrandrine on spontaneous catecholamine release were measured by
detecting the release during a 15-min incubation of cells with differ-
ent tetrandrine concentrations. The samples were filtered through a
0.2 m m pore filter, dihydrobenzoylamine (DHBA, 340 ng/ml) was
added as standard and L(+)ascorbic acid (24 mM final concentration)
was used as antioxidant. The samples were frozen at –20C° and the
catecholamine content was measured within one week by HPLC and
electrochemical detection (Biometra). Because of the low amount of
dopamine released in control experiments (<3% of catecholamines),
only epinephrine and norepinephrine were included in the HPLC
analysis.
Fluorometric measurements of [Ca]i. For video imaging experiments,
cells were cultured on glass dishes covered with collagen in 60 mm
petridishes.
The medium was removed from the petridishes and replaced with
HBS, pH 7.3 containing 1 m M fura-2/acetoxymethylester. After incu-
bation for 45 min at 37°C, the fura-2 containing HBS was removed
and cells were washed for 30 min in fura-2 -free HBS in an open per-
fusion microincubator (Bachofer) mounted on an inverted microscope
(Zeiss Axiovert). Fluorescence from chromaffin cells was monitored
simultaneously using digital imaging fluorescence microscopy (PTI)
of 2–7 cells/coverslip. Fluorescence images were obtained through an
oil immersion objective (40 « ) and visualized with a video camera
(SIM-ICCD-04). Ratios were obtained by division of two back-
ground-corrected images, one obtained at the excitation wavelength
of 340 nm, the other at 380 nm. For determination of R-min and R-
max values we used HBS with 10 m M ionomycin and 10 m M gramici-
din in the presence of 10 mM CaCl2 (R-max) and HBS without calci-
um supplemented with 1 mM EGTA (R-min) in a set of calibrating ex-
periments. Fluorescence ratios were converted in calcium concentra-
tions by the formula given by Grynkievics et al. (1985).
Tetrandrine was a gift from the Institute of Health, Bejing, Peoples
Republic of China. It was dissolved in acidified distilled water to
stock solutions of 2 mM or 4 mM. The addition of tetrandrine to the
HBS did not significantly alter the pH of the solution nor did it inter-
act with fura-2 at a concentration of 100 m M. Thapsigargin was from
Sigma.
Statistics. The results are presented as mean – SD. For statistical test-
ing we used ordinary Anova and a nonparametric posttest (Dunn’s), if
not indicated otherwise.
Results
Tetrandrine blocked calcium channel currents in bovine
chromaffin cells in a concentration-dependent manner. Cur-
rents were measured in the whole cell configuration and
were elicited by voltage steps from a holding potential of
–70 mV to 0 mV. Different concentrations of tetrandrine
were applied after control currents became stable. After
10 min, the blockade induced by tetrandrine reached a
steady-state level. The IC50 was 10.4 – 1.6 m M (Fig. 1).
A blockade of voltage-operated calcium channels
should result in a reduction of the depolarisation-induced
catecholamine release, measured by catecholamine deter-
mination in the buffer solution. We chemically depolarised
the cells with 50 mM K+ (5 min) and compared the cate-
cholamine release of tetrandrine-treated cells (1 m M,
10 m M, 100 m M) with that of untreated controls. Tetran-
drine reduced the secretion of catecholamines significantly,
an effect which is probably related to the blockade of volt-
age-operated calcium channels. 100 m M tetrandrine re-
duced the K+-evoked release significantly (Fig. 2).
To assess effects of tetrandrine on the spontaneous cate-
cholamine release cells were incubated for 15 min with dif-
ferent tetrandrine concentrations. Tetrandrine itself elevat-
ed the amount of spontaneously released catecholamines.
100 m M tetrandrine increased the amount of released cate-
cholamines significantly (Fig. 3). 1 m M (data not shown)
and 10 m M tetrandrine showed no significant effect.
In calcium-free buffer we found no increase of sponta-
neously released catecholamines up to a concentration of
200 m M tetrandrine (data not shown).
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Fig. 1  Inhibition of calcium channel currents of chromaffin cells by
various concentrations of tetrandrine, measured in the whole cell con-
figuration of the patch clamp technique. The number of cells treated
with equal concentrations is indicated above the error bars. The IC50
was 10.4 m M. Cells were clamped to –70 mV and depolarized to 0 mV
for 100 ms as indicated in the inset which shows a current trace dur-
ing treatment with 20 m M tetrandrine
Fig. 2  Amount of catecholamines (ng/ml) released in the absence or
presence of the depolarizing stimulus 50 mM K+ (5 min). (K) repre-
sents the stimulated control, (sp) represents the unstimulated control
(5 min). K1Tet, K10Tet and K100Tet represents the amount of cate-
cholamines released by K+ in the presence of 1 m M, 10 m M and
100 m M tetrandrine, respectively. * P<0.05 for comparison with K
To investigate whether tetrandrine induces elevation of
[Ca]i, we performed fluorometric measurements using
fura-2 as calcium indicator and a video imaging system on
the single cell level.
The first experiment was carried out to measure [Ca]i
during chemical depolarisation with 50 mM K+ similar to
the catecholamine release experiments. 50 mM K+ induced
a strong elevation of [Ca]i which was blocked by 100 m M
tetrandrine (Fig. 4). This was expected from our electro-
physiological investigations and catecholamine release ex-
periments. Similar to electrophysiological experiments
(Bickmeyer and Wiegand 1993; Weinsberg et al. 1994), the
blockade was hardly reversible. There was a large tetran-
drine-induced [Ca]i elevation (Fig. 4). We performed fur-
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Fig. 3  Amount of catecholamines (ng/ml) spontaneously released un-
der control (C) conditions and in the presence of 10 m M and 100 m M
tetrandrine (15 min). * P<0.05 for comparison with C
Fig. 5  a Elevation of fluorescence ratio induced by various concentra-
tions of tetrandrine in calcium-containing buffer. bl represents basel-
ines in cells before treatment. * P<0.05, Anova for repeated measures,
Wilcoxon signed rank test. Each column represents data from at least
14 cells. b Elevation of fluorescence ratio induced by various concen-
trations of tetrandrine in calcium-free buffer (2–3 min). bl represents
the baseline of cells before treatment. * P<0.05, Anova for repeated
measures, Wilcoxon signed rank test. Each column represents data
from at least 9 cells. c Elevation of [Ca]i induced by various concen-
trations of tetrandrine in the presense ( n ) and in the absense of extra-
cellular calcium ( s ). Each point represents the result from at least 9
cells. * P<0.05 between both conditions at the same concentration
Fig. 4  a Depolarization-evoked (K+) increase of [Ca]i in 4 cells in the
absence and presence of 100 m M tetrandrine (Tet). Tetrandrine blocks
depolarization induced calcium entry and this effect is hardly revers-
ible. Note the tetrandrine-induced increase of [Ca]i. b Increase of
[Ca]i measured during subsequent stimulation with 50 mM K+ in con-
trols and tetrandrine treated cells. Data are calculated by dividing the
values during a second K+-depolarization (K2) through the values
during the first K+-depolarization (K1) in controls (C) and in tetran-
drine treated cells. * P<0.0001; Students t-test
ther experiments to investigate the concentration-response
relationship of this tetrandrine effect. Tetrandrine was used
in the concentration range between 0.1 m M and 100 m M and
we found a concentration-dependent elevation of [Ca]i in
response to tetrandrine in calcium-containing buffer
(Fig. 5a). In calcium-containing buffer there was a signifi-
cant [Ca]i elevation at all tested tetrandrine concentrations
(Fig. 5a; Anova repeated measure, Wilcoxon signed rank
test; P<0.05).
We performed similar experiments as described above to
obtain a possible concentration-response relationship in
calcium-free buffer (supplemented with 1 mM EGTA) and
also found a significant elevation of [Ca]i by tetrandrine at
a concentration of 100 m M (Fig. 5b).
Comparing the [Ca]i responses to tetrandrine obtained
in calcium-free and calcium-containing buffer (Fig. 5c), we
conclude that there is a major contribution of extracellular
calcium to the tetrandrine-induced elevation of [Ca]i. Nev-
ertheless, these data demonstrate the ability of tetrandrine
to release calcium from intracellular stores.
Because of the relatively long latency (1–2 min) of [Ca]i
elevations by tetrandrine, we favoured the idea of an inhibi-
tion of calcium-pumps as suggested by Leung et al. (1994)
for HL-60 cells. Therefore we investigated the interaction
of tetrandrine with thapsigargin- sensitive calcium pumps
(Thastrup et al 1990; Robinson et al. 1992). We used calci-
um-free buffer and applied tetrandrine at a concentration 
of 100 m M, and after 5–8 min we removed tetrandrine 
and added thapsigargin at a concentration of 5 m M. Under
this conditions we found no response to thapsigargin
(Fig. 6a,b). Tetrandrine seemed to deplete thapsigargin sen-
sitive calcium stores. We then added thapsigargin first and
after 5–8 min we applied tetrandrine and found a response
to tetrandrine (Fig. 6a,c). The observation of a tetrandrine-
effect after pretreatment with thapsigargin showed that te-
trandrine has additional, thapsigargin-insensitive targets.
Discussion
Tetrandrine is a natural organic substance which blocked
voltage-operated calcium channels of different types and in
different tissues (King et al. 1988, Liu et al. 1992, Wang
and Lemos 1995, Bickmeyer et al. 1996). Additionally it el-
evated intracellular calcium levels in lymphocytes (Miles et
al. 1993) and was suggested to act similarily to thapsigargin
in HL60 cells by blocking endoplasmic reticulum calcium
ATPases (Leung et al. 1994).
Our results from bovine chromaffin cells showed a con-
centration-dependent block of voltage-operated calcium
channel currents by tetrandrine, a concentration-dependent
reduction of K+-stimulated catecholamine release and a
concentration-dependent increase of the spontaneous cate-
cholamine release. We also showed a concentration-depen-
dent elevation of [Ca]i levels in the absence and presence of
extracellular calcium, demonstrating the ability of tetran-
drine to release calcium from intracellular stores. A deple-
tion of intracellular stores led to a store-operated calcium
influx in chromaffin cells, which weakly triggered a release
of catecholamines (Powis et al. 1996). This pathway might
be one reason for the increase in spontaneous catechola-
mine release by tetrandrine in our experiments. Takemura
et al. (1995) reported a block of store-operated calcium en-
try in specific cell types, and in other cells like PC12 cells
tetrandrine only partially blocked this pathway. In chroma-
ffin cells tetrandrine did not block store-operated calcium
entry (unpublished observations).
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Fig. 6  a [Ca]i levels during treatment with 5 m M thapsigargin after
pretreatment with 100 m M tetrandrine (Thap after Tet; n = 22) and
100 m M tetrandrine after pretreatment with 5 m M thapsigargin (Tet af-
ter Thap; n = 15) in calcium free solution. * P<0.05 (nonparametric
test; Mann-Whitney). b Original traces of [Ca]i of 3 cells, treated with
100 m M tetrandrine (Tet) and successively with 5 m M thapsigargin
(Thap). c Original traces of 3 cells treated with 5 m M thapsigargin
(Thap) and successively with 100 m M tetrandrine (Tet)
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Tetrandrine inhibited effects of subsequently applied
thapsigargin, but increased [Ca]i after pretreatment with
thapsigargin. Thapsigargin is believed to block selectively
calcium ATPases of the endoplasmic reticulum (Thastrup et
al. 1990). Tetrandrine obviously had additional targets
which, we suppose, may include plasmalemmal calcium
pumps. Removal of extracellular calcium decreased [Ca]i
levels in chromaffin cells, suggesting that under resting
conditions the [Ca]i level is partially maintained by calcium
influx. Therefore an inhibition of plasmalemmal calcium
pumps would increase [Ca]i levels more efficiently than
thapsigargin and would be more effective in calcium-con-
taining than in calcium-free solution.
We conclude that tetrandrine blocks voltage-operated
calcium channels and increases [Ca]i by a blockade of en-
doplasmic and other calcium pumps.
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